Lexaria Bioscience sets Jan 14, 2025 annual/special meeting; director nomination deadline Nov 25

Lexaria Bioscience Corp.

Joint Annual and Special Meeting scheduled for January 14, 2025.
Stockholder approval required for Private Placement Warrants issued in October 2024.
Director nominee submissions due by noon ET on November 25, 2024, to Vanessa Carle.
Submission address: vcarle@lexariabioscience.com; Schedule 14N required.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.